Author

Hui Xu

University of Illinois Urbana-ChampaignORCID 0000-0002-1773-3978Unclaimed ORCID profile · follow to get notified of new preprints

Additional preprints under this name without ORCID

Hui Xu4 papers · East Carolina University

Biology Disciplines

Click to filter author papers

Bioengineering· 2 Synthetic Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Organism:human· 3 Research Focus:cancer & tumor microenvironment· 2 Assay:bulk RNA-seq· 1 Assay:CRISPR screen· 1 Research Focus:drug response / drug discovery· 1 Research Focus:protein design· 1 Assay:proteomics· 1

Frequent Co-Authors

Brendan A.C. HarleyiD· 2 shared Jann Nagina SarkariaiD· 2 shared Kim A. SeltingiD· 2 shared Sara PedróniD· 2 shared Achal Anand· 1 shared Angad P. MehtaiD· 1 shared Catherine Best-PopescuiD· 1 shared Diego J. Orea· 1 shared

Activity by Year

2024-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 22 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersBioengineering

Brendan A.C. HarleyORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

BioengineeringClinical and Translational Radiation OncologyPeer-reviewedMay 30, 2026

Biomimetic model for the identification of distinctive microenvironmental factors in glioblastoma radiosensitivity

Ryan Yao, Isabella Rivera, Jorge Maldonado…·Sara Pedrón

This study uses 3D hydrogel models to investigate how extracellular matrix, hypoxia, and neuronal cells affect glioblastoma radiosensitivity, identifying potential strategies to improve treatment.

DOI 10.1016/j.ctro.2026.101204

humanexperimental assay

𝕏 PostBluesky

Synthetic BiologybioRxivPreprintDec 24, 2024

Virus-free continuous directed evolution in human cells using somatic hypermutation

Stanley Bram, Diego J. Orea, Graeme Lindsey…·Angad P. Mehta

This paper develops a continuous directed evolution platform in human B cells using somatic hypermutation to evolve proteins with diverse mutations.

2 citations

humanCRISPR screen

𝕏 PostBluesky

BioengineeringAdvanced TherapeuticsPeer-reviewedSep 11, 2024

Targeting glioblastoma tumor hyaluronan to enhance therapeutic interventions that regulate metabolic cell properties

Edward R. Neves, Achal Anand, Joseph Mueller…·Sara Pedrón

This study investigates how glioblastoma cells use hyaluronan to support proliferation and resistance, proposing a combination treatment targeting HA synthesis and degradation.

12 citations

humanbulk RNA-seq

𝕏 PostBluesky